Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lamarca

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative StudySuraiya Dubash, Tara D Barwick, Kasia Kozlowski, et al.
Endocrine-Related Cancer|June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETsLouis de Mestier, Angela Lamarca, Jorge Hernando, et al.
Journal of Hepatology|June 5, 2025
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancerFlorian Castet, Carles Fabregat-Franco, John Bridgewater, et al.
Journal of Neuroendocrinology|December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task ForceVikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Cancer Cell|July 23, 2021
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunityColin Hutton, Felix Heider, Adrian Blanco-Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)Jaume Capdevila, Nicola Fazio, Carlos Lopez, et al.
British Journal of Cancer|July 6, 2021
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Neuroendocrinology|January 28, 2021
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU StudyPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Angela Lamarca, et al.
Neuroendocrinology|June 22, 2026
Proximal-to-distal gradient and its implications in differentiation and prognosis in colorectal neuroendocrine neoplasms: the RGETNE-HERACLES studyGermán Iglesias Álvarez, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 8, 2024
Somatostatin Receptor Imaging with [<sup>18</sup>F]FET-βAG-TOCA PET/CT and [<sup>68</sup>Ga]Ga-DOTA-Peptide PET/CT in Patients with Neuroendocrine Tumors: A Prospective, Phase 2 Comparative StudySuraiya Dubash, Tara D Barwick, Kasia Kozlowski, et al.
Endocrine-Related Cancer|June 1, 2021
Treatment outcomes of advanced digestive well-differentiated grade 3 NETsLouis de Mestier, Angela Lamarca, Jorge Hernando, et al.
Journal of Hepatology|June 5, 2025
Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancerFlorian Castet, Carles Fabregat-Franco, John Bridgewater, et al.
Journal of Neuroendocrinology|December 9, 2024
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task ForceVikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Cancer Cell|July 23, 2021
Single-cell analysis defines a pancreatic fibroblast lineage that supports anti-tumor immunityColin Hutton, Felix Heider, Adrian Blanco-Gomez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2021
Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors: Results of the Phase II TALENT Trial (GETNE1509)Jaume Capdevila, Nicola Fazio, Carlos Lopez, et al.
British Journal of Cancer|July 6, 2021
Correction: Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
British Journal of Cancer|July 23, 2020
Current and novel therapeutic opportunities for systemic therapy in biliary cancerJosé J G Marin, Maria Giuseppina Prete, Angela Lamarca, et al.
Neuroendocrinology|January 28, 2021
External Validity of Somatostatin Analogs Trials in Advanced Neuroendocrine Neoplasms: The GETNE-TRASGU StudyPaula Jimenez-Fonseca, Alberto Carmona-Bayonas, Angela Lamarca, et al.
Neuroendocrinology|June 22, 2026
Proximal-to-distal gradient and its implications in differentiation and prognosis in colorectal neuroendocrine neoplasms: the RGETNE-HERACLES studyGermán Iglesias Álvarez, Jaume Capdevila, Rocio Garcia-Carbonero, et al.
Pageof 21